(1433 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
Severe type 2 asthma: phenotypes and precision treatment for patientsOpening remarks Stephanie Korn, Enrico Hef...
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?Welcome & Introduction Jonathan Grigg...
-
IgE in asthma and nasal polyposis: your questions answered
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascadeIoana Agache, Andrew Menzies-gow, Stephanie Korn, Celeste Porsbjerg
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseasesWelcome and introduction Peter Howarth, G....
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?Guy Brusselle, Klaus F. Rabe This Company Sponsored Symposia ha...
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks Santiago Quirce ...
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
IL-5 inhibition in CRSwNP and severe asthma: impact beyond the eosinophilWelcome For the sci...
-
Targeting eosinophils in severe asthma: real-world data and clinical remissionChair’s welcome Biologics ...
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Pediatric Severe Asthma: Why Lung Function Matters
-
Reconsider the art of AITWelcome and introduction Pati...
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
Patients with peanut allergy: the hope for a better life?Introduction Antonella Muraro ...
-
Allergic patient: The Real WorldIntroduction European patient...
-
Efficacy and quality of life in HAE: The lanadelumab experience
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
Show more Sponsored Symposia (22)Show Less-
-
DGAKI statement on asthma and COVID-19AIT and COVID-19 March 18, 2020 Dear colleagues, In the past few days, we have received mo...
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma For the EU‐funded project PERMEABLE (PERsonalized MEdicine Approach for asthma and aller...
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma RegistryDespite the clinical burden of severe asthma is substantial, there is evidence of a neutra...
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma SectionAbstract Background The restrictions imposed by the COVID-19 pandemic impact heavily the m...
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohortThe PeARL multinational cohort included 1,054 children with asthma and 505 non‐asthmatic...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in DaeguIn summary, despite the differences depending on phenotypes, the prevalence of asthma was ...
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthmaHigh expression of such endopeptidases may be associated not only with a higher risk of SA...
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & PreventionCoronavirus disease 2019 (COVID‐19) has rapidly spread worldwide, posing a serious publi...
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2Asthma and respiratory allergies have not been identified as risk factor for severe Covid-...
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in BeijingThe results support the recommendation that patients continue taking their prescribed asth...
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsIn conclusion, in our large cohort of severe asthmatics, only a small minority experienced...
Show more Covid-19 (10)Show Less-
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)An ARIA-EAACI statement has been devised to make recommendations on asthma, and not necess...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force ReportAbstract Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis a...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
Show more Position Papers (21)Show Less-
-
Elderly asthma
-
Viral infection and asthma
-
Bronchiectasis and severe asthma
-
Immunotherapy in severe asthma (AIT)
-
Late onset T2 asthma – a case study
-
Updates in [severe] asthma in adults
-
Tezepelumab (anti-TSLP) in asthma
-
Targeted approaches for asthma
-
The basics of severe asthma - biomarkers
-
Difficult to control asthma in children
-
Difficult to control asthma in adults
-
Exercise: induced asthma and rhinitis
-
Big changes in asthma treatment : GINA 2019
-
Focus on Patient. Personalised therapy for severe asthma
-
Implementation of telehealth in asthma management: trials and tribulations
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Early life wheeze - risk factors for asthma in school age
-
A system biology and machine learning approach to childhood asthma
-
Impact of climate change on asthma exacerbations
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
How to select and follow a biological for asthma and CRSwNP
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Development of a childhood asthma prediction model using machine learning approaches
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
-
Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience
-
House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
-
Severe Asthma and COVID-19
-
Electronic Health in Severe Asthma
-
Asthma: phenotypes to endotypes
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Asthma management during the COVID-19 pandemics
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance
-
Asma e alergia em Angola
-
Inflammatory biomarkers
-
Asma e alergia em pandemia
-
Lung function testing
-
Novel pharamacological targets
-
GINA Guidelines Update
-
Launch of the Biological guidelines
-
What is the immunological basis for new biologicals?
-
How to improve outcomes
-
Bronchial allergen challenge in the clinic
-
Phenotypes and Endotypes
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Elevated tryptase – Now what?
-
Plans of GARD in terms of surveillance after COVID
-
AAAAI Practice Parameters
-
Microbiota in immune-based therapies
-
The engineering-medicine interface
-
Should we do patch testing in children with eczema?
-
Novel approaches of allergen immunotherapy
-
Big data and cluster analysis: a real life perspective
-
Anaphylaxis in ICD-11
-
What’s different about the adolescent brain?
-
Danger signs
-
Update on drug allergy
-
AI models
-
Gut microbiome - based therapeutic approaches
-
Virtual care, social media and mHealth for allergy management
-
Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction
-
An update on food allergy
-
Telemedicine and Tele-health
-
Adherence: A challenge for Immunotherapy
-
Nasal allergen challenge
-
Treating allergic patients during the COVID-19 pandemic
-
Big Data Analysis: MetabolomicsView Presentation
-
Sleep patterns and development of children with atopic dermatitis
-
Current and future perspectives
-
How do allergens sensitize?
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
Living with food allergy
-
Risk assessment and active management of food allergy
-
Measles infection causes immune amnesia
-
Chronic rhinosinusitis with nasal polyps
-
Vaccines- Is this the tool to end the pandemic?
-
Update of the WAO anaphylaxis guidance
-
Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
AIT in the pediatric population
-
Bronchial allergen challenge in research
-
Cellular tests for the diagnosing and monitoring of allergy
-
Tackling anaphylaxis
-
Eosinophilic fasciitis, an unusual presentation
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
New perspectives for anaphylaxis
-
Oral food challenges thresholds for clinical reactions
-
How to keep a child with anaphylaxis safe in school
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
New insights in urticaria mechanisms
-
Desensitization in chemotherapy and biologics
-
Can we prevent the development of food allergy?
-
Tree nut allergy: path from national to global data
-
Allergy to Kale
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Can group consultations work in allergy? Learning from rheumatology
-
Food allergy: new allergens on the block
-
Is IgA a piece of the EoE puzzle?
-
Assessment of adherence to treatment using mHealth
-
The ‘allergy tool kit’ for the transition clinic
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Primary care in CRDs during COVID
-
Delabelling adults
-
Evidence of immunotherapy on allergy prevention?
-
Allergen immunotherapy for food allergy
-
Unusual presentations of contact dermatitis
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Route of exposure determines the immune response to food allergens
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
Current status on prophylaxis in HAE
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Hypereosinophilic syndromes and autoimmunity
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Challenges on the implementation of early introduction of allergenic foods
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Recognizing immediate reactions in contact dermatitis
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Immunological basis of food aversion
-
Moisturisers for the primary prevention of food allergy
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Impact of climate change on the immune system
-
Anti IL4/13 and IL33/TSLP
-
Exercise-induced urticaria and anaphylaxis
-
Impacting quality of life with PALFORZIA
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Occupational respiratory allergy in food processing industries
-
Neuroimmunology and allergy
-
Differential diagnosis
-
Hologenome and obesity
-
Covid 19 and air pollution: is there a relationship?
-
Air pollution and allergy: call for action!
-
Preparing a grant: Dos and Don'ts
-
What do we learn from subgroup analyses in phase-III trials?
-
EAACI Guidelines on environmental health
-
Phenotypes and endotypes of occupational allergy
-
How to use social media in your professional practice: the clinician perspective
-
Precision Medicine and AIT
-
Food allergy - the beginners guide
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Prevention and therapy in primary immunodeficiencies: Vaccination
-
Global impact of the COVID-19 on the environment
-
How to evaluate lung function? Hands-on plus lecture
-
Lesson learned from the pathogenesis of SARS-COV2
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Skin care from birth for allergy prevention: results today
-
The clinical clues and pitfalls in contact dermatitis
-
Hypersensitivity to antiepileptic drugs
Show more Event Resources (183)Show Less-
Website
Collapse
-
Non-T2-high asthma
-
Flash talks on asthma
-
Biologicals in asthma
-
MCID in severe asthma
-
Allergy asthma and sport
-
Flash talks on asthma II
-
Interleukin 33 and asthma
-
Allergic rhinitis and asthma
-
Epigenetics in severe asthma
-
Diagnosis of pediatric asthma
-
Th17 pathway in severe asthma
-
Management of pediatric asthma
-
Novel targets in severe asthma
-
The concept of asthma remission
-
Flash talks on asthma treatment
-
Breathomics in asthma diagnosis
-
Targeting TSLP in severe asthma
-
United airways in severe asthma
-
The concept of asthma remission
-
Triple therapy in severe asthma
-
Non-allergic rhinitis and asthma
-
Managing asthma during pregnancy
-
Neurogenic inflamation in asthma
-
Innate immunity in severe asthma
-
Doctor, does my baby has asthma?
-
Doctor, does my baby has asthma?
-
Learn the basics of severe asthma
-
Resolution: beyond asthma control
-
Tackling severe asthma in real life
-
Targeted treatment in severe asthma
-
Treatment of severe asthma (update)
-
MASK-air experience in severe asthma
-
Prevention on pediatric severe asthma
-
Therapeutic options for non T2 asthma
-
Predictive markers of asthma remission
-
Inflammatory pathways in severe asthma
-
Obesity, inflammation and severe asthma
-
The next era in severe asthma management
-
Optimising asthma management in children
-
The role of TSLP in driving severe asthma
-
EAACI nomenclature for allergy and asthma
-
Management of severe asthma in adolescents
-
Severe asthma with eosinophilia versus HES
-
Microbial triggers of asthma exacerbations
-
Can carpets be asthma & allergy friendly?
-
Novel therapeutic approaches in severe asthma
-
Prevalence and phenotypes of pediatric asthma
-
The central role of patients in severe asthma
-
Childhood asthma: pathogenesis and phenotypes
-
Utility if breathomics in the diagnosis asthma
-
Comorbid asthma and CRSwNP: the patient impact
-
Root and branch of childhood asthma management
-
Management of pediatric asthma – What is new?
-
Biomarkers for allergen immunotherapy in asthma
-
From preschool wheezing to asthma: determinants
-
Green spaces and allergy and asthma development.
-
Exhaled nitric oxide in the management of asthma
-
Genome-wide association studies in severe asthma
-
AstraZeneca - The epithelial era in severe asthma
-
Immunological phenotyping of asthma exacerbations
-
The role of exhaled biomarkers in pediatric asthma
-
Treatment on chronic rhinitis and impact on asthma
-
Bronchiolitis and future risks for childhood asthma
-
CSN5 is a circulating marker for asthma exacerbation
-
Microbiota, children wheeze and adult asthma severity
-
Development and protection in pediatric severe asthma
-
How can we address the excess reliever use in asthma?
-
Biological treatment of severe asthma during pregnancy
-
The role of p300 in the pathogenesis of allergic asthma
-
Extreme air conditions i.e.Thunderstorms etc and asthma
-
Allergic bronchopulmonary aspergillosis revealig asthma
-
Occupational asthma endotyping: the past and the future.
-
New Epidemiologic Factors Related to allergy and asthma
-
Evaluation of the TGF-beta isoforms in asthmatic patients
-
Evaluation of the TGF-beta isoforms in asthmatic patients
-
Biologicals in asthma - from clinical trials to real life
-
Biologicals in asthma - from clinical trials to real life
-
High dose ICS in children with recurrent wheeze or asthma.
-
Overlap of severe asthma and alpha-1 antitrypsin deficiency
-
Measuring adherence to inhaled asthma controller medication
-
Biomarker-guided approach for treatment of preschool asthma
-
Biomarker-guided approach for management of preschool asthma
-
Is there a role for allergen immunotherapy in severe asthma?
-
Beyond eosinophils: the broader role of IL-5 in severe asthma
-
Filling the knowledge gaps in asthma: Real-world evidence data
-
The genetic variability of treatment response in severe asthma
-
Beyond inflammation in severe asthma: the central role of TSLP
-
Novel analytical tools to endotype asthma and allergic diseases
-
Biomarkers can guide the choice of a biological in severe asthma
-
Serum testosterone and obese asthma phenotypes: the story of men
-
Immunodeficiency accompanying severe asthma and chronic urticaria
-
Biological for asthma: who, which one and how to assess response?
-
Tezepelumab: the new promise to challenge severe asthma complexity
-
Prevalence of bronchial asthma in children and adolescents in Poland
-
The impact of asthma on Post COVID Condition (PCC) and COVID symptoms
-
Personalized application of Biologics in pediatric allergy and asthma
-
Updates in the association between air pollution, allergy, and asthma.
-
Redefining ambition: Looking to the future of severe asthma management
-
Discrepancy between lung function and symptoms in a severe asthma case
-
Early immune development – relevance for allergic diseases and asthma
-
Immunodeficiencies and airway infections in severe asthma exacerbations
-
Therapeutic implications of the comorbidities of severe allergic asthma
-
Vaccination against SARS-CoV2 COVID-19 in patients with bronchial asthma
-
Diagnosis of allergic asthma – recommendations of the EAACI Guidelines
-
Allergy and Asthma - Session 2: Precision medicine in pediatric asthma
-
The T2 spectrum of asthma patients in an expert clinic in the Netherlands
-
The potential of anti-infectives and immunomodulators in pediatric asthma
-
Omics technologies in allergy and asthma research: An EAACI position paper
-
Case 1 – Jordi: United airways – connection between rhinitis and asthma
-
Endotyping occupational asthma: progress and challenges in current practice
-
Hypersensitivity reactions to biologic agents in patients with severe asthma
-
The effects of the endocrine disruptors on asthma: bisphenolA and phthalates
-
Case 3 – Flora: Anaphylaxis – Connection between asthma and food allergy
-
Dual biologics therapy in a patient with severe asthma and chronic urticaria
-
Early events in infancy and the development of asthma, allergy and tolerance
-
Epigenetic regulation of early and late asthmatic reactions in allergic asthma
-
Metabolomic analysis of bronchoalveolar lavages from severe asthmatic children
-
Prevalence and risk factors for asthma among adults in an East African country
-
Diagnostic accuracy of cereal-specific IgE in flour-induced occupational asthma
-
Biologicals in asthma and atopic eczema in elderly: age-specific considerations
-
Chronic eosinophilic pneumonia and asthma: a diagnostic and management challenge
-
Distinct activation of major nasal phenotypes in wheezing and asthmatic children
-
Effect of inhalation formulation on bronchial obstruction in teen-aged asthmatics
-
Occupational dust mite asthma in a thrift shop company : A case report of 9 cases
-
Dupilumab in improving control of severe asthma in real life. Report of two cases
-
Biomarkers to predict long-term outcomes in childhood asthma: A systematic review
-
Nasal interferon-swap in wheezing and asthmatic children carrying 17q21 risk allel
-
Omalizumab for severe food allergy in a large Italian cohort of asthmatic children
-
Polymorphism of Тumor necrosis factor-alpha gene in children with bronchial asthma
-
Environmental influences on allergy and asthma development – what is detrimental?
-
The importance of assessing obstructive sleep apnoea (OSA) in adult asthma patients
-
Interleukin 1-beta correlates with cough reflex sensitivity in children with asthma
-
Things to keep in mind in the differential diagnosis of severe asthma: ABPA and EGPA
-
Hesperidin ameliorates asthma by regulating the barrier function of epithelial cells
-
Hesperidin ameliorates asthma by regulating the barrier function of epithelial cells
-
Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma
-
Anaphylaxis and occupational asthma allergic caused by carmine ( E-120): a case report
-
Farm-dust mediated upregulation of activated B-cells in asthmatic and healthy children
-
Work-related asthma, from phenotypes to endotypes: when did we start and where are we?
-
Difficult-to-treat asthma: importance of additional investigation in pediatric patients
-
GSK Medical - IL-5 inhibition in CRSwNP and severe asthma: impact beyond the eosinophil
-
Treating to remission: is it achievable in severe eosinophilic asthma in the real world?
-
The interaction effect between genetic risk score and obesity on asthma and lung function
-
Farm-dust mediated asthma protection in childhood: Dendritic cell-mediated T cell priming
-
Transcriptomic studies of response to biologicals in severe asthma; what do they suggest?
-
Biologics targeting eosinophils in severe asthma: what is the real-world evidence to date?
-
Assessment of systemic inflammation and asthma control in asthma patients with elevated BMI
-
Unraveling new biomarkers for asthma treatment monitoring with biologics using metabolomics
-
Could specific IgE sensitization patterns to dog molecular allergens determine asthma risk?
-
AstraZeneca - Targeting eosinophils in severe asthma: real-world data and clinical remission
-
A study on the association of asthma onset in infants and toddlers with croup using big data
-
Antibiotic prescription practices for acute asthma exacerbations: results of an EAACI survey
-
Effects of allergic comorbidities and aeroallergen sensitization on childhood asthma severity
-
Towards standardisation of clinical outcomes used in allergen immunotherapy in allergic asthma
-
Evaluation if probiotics may ameliorate ovalbumin-induced atopic dermatitis and asthma in mice
-
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
-
Respiratory allergic manifestations (asthma and rhinitis) in children followed for food allergy
-
The development in confirmed asthma and allergy diagnoses at Allergy Center AUH through 10 years
-
A prospective study of cognitive and olfactory function in patients with moderate to severe asthma
-
Single house dust mite allergens as potential biomarkers for allergic asthma and atopic dermatitis
-
Biological treatment in severe asthma phenotype overlap- insights from a tertiary pulmonary centre
-
Features of sensitization and genetic factors in the development of asthma in the Kazakh population
-
Differential gene expression in cord blood associated with childhood asthma diagnosis later in life
-
Significant bronchodilator response in oscillometry and spirometry in relation to asthma and wheeze
-
AstraZeneca - Transforming asthma care for a broad population of severe uncontrolled asthma patients
-
The relationship between asthma and mental health conditions in national samples of Canadian children
-
Critical window of microbial colonization for shaping innate immunity and its relation to asthma risk
-
Fiber rich food suppressed airway inflammation, GATA3+Th2 cells and FcεRI-alpha+ Eosinophils in asthma
-
Anaphylaxis due to anti-asthmatic biologics: analysis of VigiBase®, the WHO pharmacovigilance database
-
Viral etiologies of preschool wheezing and how do they relate to different phenotypes of preschool asthma
-
Evaluation of asthma control and quality of life in elderly patients under biological monoclonal antibody
-
Guinea pig domestic exposure could be associated to severe forms of allergic asthma and allergic rhinitis
-
Self-reported and physician diagnosed asthma amongst allergic rhinitis patients enrolling in an ILIT trial
-
Cannabinoid receptor 2 as a regulator of inflammation induced by oleoylethanolamide in eosinophilic asthma
-
Reduction of systemic corticosteroid courses in severe asthmatic patients receiving a biological treatment
-
Antibiotic stewardship in asthma exacerbations: outcomes and recommendations of an EAACI task force survey
-
Trends in asthma among children in Denmark, Finland, Norway and Sweden in nationwide register-based cohorts
-
Patient-centred composite index for assessment of response to biological therapy for paediatric severe asthma
-
Experience of omalizumab treatment of severe bronchial asthma combined with severe vernal keratoconjunctivitis
-
Analysis of differentially expressed microRNAs and their target genes in lung tissue from asthmatic individuals
-
The polybacterial mucosal vaccine MV130 impairs airway inflammation in a HDM-induced eosinophilic asthma model
-
The impact of anti-IL5 therapies in allergic patients with severe asthma, with and without fungal sensitization
-
Preventive counseling on the risk factors of the population with asthma or chronic obstructive pulmonary disease
-
Blood sphingolipid profiling of obese and lean asthmatic children from Middle East and North Africa (MENA) region
-
Dupilumab is effective in children (6–11 years) with moderate-to-severe asthma and high eosinophils at baseline
-
Global, regional, and national trends in incidence of asthma: findings from the Global Burden of Disease Study 2019
-
The roles of FeNO in predicting asthma and sensitization to common aeroallergens in patients with allergic rhinitis
-
Study of the effectiveness of the Connect 360 Program for the control of our asthmatic Benralizumab treated patients
-
Predicting factors for response to mepolizumab after 3 years of follow up in patients with severe eosinophilic asthma
-
Regular use of nasal powder methyl-cellulose in asthma patients with associated rhinitis reduces asthma exacerbations
-
Industry Symposium - AstraZeneca Italy Symposium - Tezepelumab the firstand only anti- TSLP biologic in severe asthma
-
Prostaglandin, fatty acid, and glycerophospholipid measurements in breath samples can identify individuals with asthma
-
Analysis of the gene expression of four potential asthma triggers in peripheral and lung samples of asthmatic patients
-
Severe uncontrolled allergic asthmatic patients display a specific miRNA profile associated to asthma and inflammation
-
Impact of sublingual immunotherapy on asthma onset in patients with allergic rhinitis: results from the EfficAPSI study
-
Differences in baselinecharacteristics of bionaïve and switchers to anti-IL4/IL13 treatment in servere asthma patients
-
Response to treatment with dupilumab in patients with asthma and/or chronic rhinosinusitis and nasal polyposis (CRScNP)
-
A survey of the parental experience of colour-coded written asthma management plan for home-based parent-led asthma care
-
Characteristic analysis of asthmatic airflow using computed tomography images incorporating computational fluid dynamics
-
Severe bronchial hyperresponsiveness along with house dust mite allergy indicates persistence of asthma in young children
-
Cat exposure, IgE and IgG4 antibodies to cat allergens, and asthma in a birth cohort; The modified Th2 response revisited
-
Understanding the effect of clinical baseline characteristics on SABA reliever use in patients with moderate-severe asthma
-
Longitudinal trajectories of childhood asthma phenotypes and allergic comorbidities in Korean childhood Asthma Study (KAS)
-
Lung function in asthmatic old patient under antibody monoclonal therapy: the experience from a Portuguese tertiary hospital
-
Characterization and evaluation of the impact of comorbidities in patients with uncontrolled asthma and SARS-COV-2 infection
-
Real-world clusters of severe asthma from the Italian Registry on Severe Asthma (IRSA): a longitudinal Latent Class Analysis
-
ORBE II: Analysis of atopic vs non-atopic patients with severe asthma treated with benralizumab in clinical practice in Spain
-
Nuclear factor of activated T cells 1 (NFATc1) in CD11c+ dendritic cells drives eosinophilic inflammation in asthmatic patients
-
Mould sensitization to Aspergillus fumigatus / Alternaria alternata and asthma control: data from the CHAMPIASTHMA French study
-
Real-life efficacy of biologicals in patients with severe asthma phenotype overlap. Experiences from a tertiary pulmonary centre
-
Industry Symposium - Chiesi Italy Symposium - New opportunity in themanagement and treatment of asthma: Extrafine Triple Therapy
-
Molecular sensitisation profile to dogs in residents of Latvia and its connection with asthma and the course of allergic rhinitis
-
Impact of single inhaler triple therapy in asthmatic patients lung function: experience of an Allergy and Clinical Immunology Unit
-
TH2 inflammation is protective against serious outcomes among inner city asthmatics infected with SARS-CoV-2 Alpha Variant (SC2AV)
-
Clinical implications of mucus plugging and mucus hypersecretion in severe asthma and the potential role of epithelial cytokines
-
Withdrawal of inhaled corticosteroids in severe T2-low obesity-related asthma: results from an open-label randomized crossover trial
-
Composition, structure, function, and interactions of the nasal bacteriomes in allergic rhinitis patients with or without comorbid asthma
-
Prevalence of asthma and asthma-related risk factors in pre-term infants based on 2002–2018 Korea national health insurance claims data
-
Bronchodilator response and methacholine testing in young children with suspected asthma: which test is more helpful in clinical practice?
-
The effect of allergen-specific immunotherapy on the quality of life of school-age children with asthma and sensitization to cat allergens
-
Impact of childhood diseases and familial asthma history on adult asthma characteristics: results from Turkish Adult Asthma Registry (TAAR)
-
The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: post hoc analysis of REALITI-A at 2 years
-
Complete vs. non-complete responders to benralizuman, mepolizumab and omalizumab in severe asthma patients: a long-term retrospective analysis
-
How epithelial cytokines affect immune cell function and the clinical consequences in allergy, severe asthma and upper airways disease
-
Impact of sublingual immunotherapy on asthma worsening in patients with allergic rhinitis and associated asthma: results from the EfficAPSI study
-
ACAAI members’ preferred step 1-3 asthma maintenance and reliever therapy and practice hurdles, mainly related to incomplete insurance coverage
-
The Dietary Inflammatory Index is related to asthma and lung function: Analysis of Korea National Health and Nutrition Examination Survey (KNHANES)
-
Eosinophilic component is ubiquitous among allergic bronchopulmonary aspergillosis with atopic, non-atopic, and sans asthma – factor analysis –
-
Mepolizumab therapy decreases epithelial-derived cytokine concentrations in exhaled breath condensates from patients with severe eosinophilic asthma
-
Dysregulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) leads to lung fibrosis in house dust mite-induced experimental asthma
-
Effectiveness and safety of house dust mite-polymerized extract in pediatric patients with allergic rhinitis and/or asthma: a prospective cohort study
-
The expression of CYSLTR2 is reduced after treatment with benralizumab in severe asthma patients with and without nasal polyposis: a prospective study
-
Biomarkers expression, treatment and disease burden in a cohort of Italian patients affected by severe asthma: a sub analysis of the ISAR EVEREST study
-
PAAI - Interactive online self-learning programme for patients with asthma: a patient-and carer-centred approach on the most relevant topics to address
-
House dust mite sublingual immunotherapy formulation for allergic asthma: A systematic review and meta-analysis of randomised and nonrandomised studies
-
Clinical characterization of severe asthma in young adults and patients with NSAID-exacerbated respiratory disease. Results of the BIOBADALER consortium
-
Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study
-
The sensitization profile in monosensitized and polysensitized children with isolated asthma, isolated rhinitis and combined rhinitis and asthma syndrome
-
Validation of cluster analysis of sputum cytokine profiles in asthmatic patients reveals underlying molecular pathways and impact of environmental triggers
-
Validation of cluster analysis of sputum cytokine profiles in asthmatic patients reveals underlying molecular pathways and impact of environmental triggers
-
Identification of two miRNA clusters in plasma-derived extracellular vesicles specifically linked to pathomechanims of obesity-associated low type-2 asthma
-
Long-term, real-world effectiveness of allergy immunotherapy in children with allergic rhinitis and pre-existing asthma. Subgroup analysis of the REACT-study
-
Prevalence of self-reported asthma and atopic comorbidities in an adult general population sample from Germany: Results from the Study of Health in Pomerania
-
Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: post hoc analysis of REALITI-A at 2 years
-
Hypersensitivity to dog allergens: dependence of the severity of symptoms of allergic rhinitis and/or asthma on sensitization to allergenic proteins of the dog
-
Der p 2, but not Blomia tropicalis specific-allergens, is a common sensitizer in children with asthma living in Bogotá-Colombia, a high-altitude tropical city
-
Combined dietary intervention with scFOS/lcFOS and Bifidobacterium breve limits airway hyperresponsiveness in a mouse model for house dust mite allergic asthma
-
Evaluating treatment responses of dupilumab versus omalizumab in severe chronic rhinosinusitis with nasal polyps and comorbid asthma patients: the EVEREST trial
-
Rhinovirus-induced epithelial RIG-I inflammasome activation suppresses antiviral immunity and promotes inflammatory responses in virus-induced asthma exacerbations and COVID-19
-
CD62Llow eosinophils proportion correlates with clinical parameters of asthma and chronic rhinosinusitis and in vivo/in vitro effect of Mepolizumab on eosinophil subpopulations
-
ILC2, MSF, PTX3 AND GAL3 regulation in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps treated with mepolizumab: study protocol
-
The impact of anti-IL5/5R therapies on reducing exacerbations and systemic corticosteroids in severe asthma: a comparison between allergic versus non-allergic asthmatic patients
-
GSK - Redefining ambition: Getting to grips with Clinical Remission in IL-5-driven severe asthma and stepping up expectations for patients with chronic rhinosinusitis with nasal polyps
-
Oral corticosteroid sparing effect of sublingual liquid immunotherapy in patients with allergic rhinitis with or without associated asthma in real practice: results from the EfficAPSI study
-
An accelerated up-dosing scheme using one strength for SCIT with a native HDM allergen extract proved safety and tolerability in Chinese children with allergic rhinitis with or without asthma
-
Specific IgG4 and sIgE Ab to mite and cat component allergens and asthma: sIgG4 responses have a controlling effect in relation to Der p 1 and Fel d 1, which have quantitatively higher exposure
-
Targeting type 2 inflammation: Use of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps and the effect on co-existing asthma. The experience of the Allergy Unit ‘’D. Kalogeromitros’ in Greece
-
Effectiveness of allergen immunotherapy (AIT) under real life conditions from a German retrospective cohort study in children, adolescents and adults with house dust mite (HDM) induced allergic rhinitis (AR) and asthma (AA)
-
The non-interventional real-life study with a combination of beclomethasone dipropionate and formoterol in HFA or DPI 100/6µg inhalers as maintenance and reliever therapy in patients with moderate persistent uncontrolled asthma
-
Asthma
-
Asthma
-
Asthma 1
-
Asthma 1
-
Asthma 2
-
Asthma 2
-
Asthma 3
-
Asthma 3
-
Tests to Diagnose Asthma
-
New Frontiers in Asthma
-
Severe Asthma registries
-
Asthma and comorbidities
-
Hot Topics in Pediatric Asthma
-
Severe Asthma: Tech it easy!
-
Asthma phenotypes in children
-
Comorbidities in Severe Asthma
-
Thymic Stromal Lymphopoietin and Asthma
-
How to set up an Asthma Center of excellence
-
Exercise-induced Asthma: What's new?
-
Aeroallergen Sensıtıvıty ın Severe Asthma
-
How to set up and Asthma Center of excellence
-
Global Initiative for Asthma (GINA) Guidleine
-
Asthma exacerbation or something else?
-
Clinical Relevance of Serum CC16 in Adult Asthma
-
Allergy and Asthma - Session 1: Diagnosing Asthma
-
Asthma pheno-endotyping for experts Part 1
-
Asthma pheno-endotyping for experts Part 2
-
Research Priorities in Severe Asthma: the EAACI view
-
Asthma endotypes: static or fluid entities?
-
The Value of Dust Mite Immunotherapy in Allergic Asthma
-
Cutting Edge in Allergy, Asthma and Immunology
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
Severe Asthma and Chronıc Eosınohılıc Leukemia
-
Impact of Type 2 Inflammation on Pediatric AD, Asthma, and EoE
-
Asthma exacerbations: towards personalised medicine
-
Practical Guide to Biomarker-Driven Pediatric Asthma Management
-
How Can Biologics Improve Lung Function in Pediatric Severe Asthma?
-
Effects of Climatotherapy on Quality of Life in Children with Asthma
-
T regulatory and Th17 Cells in Atopic Dermatitis and Allergic Asthma
-
Analysis of Subphenotypes of Patients with Asthma-COPD Overlap (ACO)
-
Impact of COVID-19 Pandemic on Childhood Asthma and Wheezing Disorders
-
Taking Steps Toward Remission: Moving Beyond Disease Control in Asthma
-
Sanofi Regeneron - Pediatric Severe Asthma: Why Lung Function Matters
-
Air Pollution Effects in Allergies and Asthma in Underserved Populations
-
Bridging the Gap Between Type 2 Inflammation and Clinical Remission in Asthma
-
Inner City Asthma: Housing as a Key Social Determinant of Health
-
Sanofi Regeneron - Clinical Remission as the Ultimate Goal in Asthma Management
-
Examining the Latest Evidence of Clinical Remission in Asthma With Biologic Use
-
The Inflammasome Inhibitor OLT1177 Improves Experimental Allergic Asthma in Mice
-
Why Is it Important to Assess Lung Function in Pediatric Severe Asthma Patients?
-
Sanofi Regeneron - On-Therapy Remission in Pediatric Asthma: Where Are We Today?
-
Asthma due to irritant agents: does it exhibit a distinct endotype?
-
Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice
-
Reliability of the Asthma Quality of Life Questionnaire in the Republic of Kazakhstan
-
Effect of Omalizumab on Asthma Outcomes in Adolescents/Adults with Asthma and Food Allergy
-
Effect of Omalizumab on Asthma Outcomes in Pediatric Patients with Asthma and Food Allergy
-
Airway Epithelial Antiviral Immunity is Enhanced by Allergen Immunotherapy in Allergic Asthma
-
Phenotypic and Treatment Efficacy Analysis of Mold-Sensitive Asthmatic Patients; SAFS, ABPA, ABPM
-
Long-term Exposure to PM2.5, PM10 and Lung Function in Adult Asthma Based on Land-use Regression
-
Trends İn Asthma Encounters and Pollution Before and After the COVID-19 Pandemic
-
Predicting trainable DAMPs in Asthma development by Integrating mRNA expression and DNA Methylation
-
Assessing Disease Activity to Better Define On Treatment Clinical Remission in Pediatric Severe Asthma
-
Obese and Non-obese Patients With Severe Asthma: Comparison of Omalizumab-Mepolizumab Treatment Outcomes
-
From the Anthropocene epoch to the One Health concept: the impact of climate change and air pollution on Asthma
-
Exploring the Interaction between Genetic Risk Score and Exercises on Asthma by a Genome-wide Association Study
-
Impact of Dupilumab Treatment on Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Asthma
-
Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence - Based Risk Prediction
-
Dupilumab Treatment Induces Clinical Remission in Patients with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
-
The Effect of an Educational Program for Children with Asthma on Airway Inflammation: Before and During the COVID-19 pandemic
-
Evaluation Of The Relationship Between Asthma Severity And Cardiac Functions By Speckle Tracking Method In Pediatric Patients
-
The 4E Non-Pharmacological Factors (Environment, Eating, Exercise, Emotion) Effects on Asthma Control Among Asthmatic Patients
-
Association between Asthma and Cardiovascular diseases: A longitudinal follow-up studies using a national health screening cohort
-
Efficacy of Dupilumab 200 mg Every 2 Weeks in Children with Moderate-to-Severe Asthma: A Post Hoc Analysis of VOYAGE and EXCURSION
-
Long-Term Safety of Dupilumab in Patients with Moderate-to-Severe Asthma Who Completed the LIBERTY ASTHMA TRAVERSE Continuation Study
-
Clinical and Biomarkers characteristics of Severe Asthma Patients who initiated Biologic Therapy: a Colombian single center experience
-
Dual Monoclonal Antibody Therapy In A Patient With Uncontrolled Severe Chronic Rhinosinusitis With Nasal Polyps and Eosinophilic Asthma
-
Dual Monoclonal Antibody Therapy In A Patient With Uncontrolled Severe Chronic Rhinosinusitis With Nasal Polyps and Eosinophilic Asthma
-
Impact of Age of Asthma Onset on the Long-Term Efficacy of Dupilumab in Patients with Type 2 Inflammation: LIBERTY ASTHMA TRAVERSE study
-
Evaluation of Omalizumab and Mepolizumab Treatment Efficacy in Severe Asthmatics Associated with NSAID-Exacerbated Airway Disease (N-ERD)
-
TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice
-
Efficacy of Dupilumab in Patients With Asthma Stratified by a Minimally Important Fractional Exhaled Nitric Oxide Reduction at Week 2 of Treatment
-
Phenotypical distribution according to Asthma age of onset in patients evaluated for biologic therapy prescription in a reference center at high altitude
-
Efficacy and Safety of Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Subjects Aged 1-3 Years With and Without Concomitant Asthma in the EPITOPE Study
-
Dupilumab Improves Lung Function and Reduces Exacerbation in Children (6 to 11 Years) With Moderate-to-Severe Asthma and High Blood Eosinophil Count at Baseline
-
Clinical Remission in Patients with Severe Eosinophilic Asthma with Benralizumab According to Body Mass Index Status in an Integrated Analysis of the Real-World XALOC-1 Study
-
Asthma Outcomes with Benralizumab in Biologic-Naïve and Biologic-Experienced Patients with Severe Eosinophilic Asthma (SEA) in an Integrated Analysis of the Real-World XALOC-1 Study
-
CHALLENGING ASTHMA CONTROL: THE PHISICIAN AS A PATIENT
-
One Health
-
Poster Walk
-
Heat stress
-
Poster Walk
-
Anaphylaxis
-
Anaphylaxis
-
Debate
-
Oral Presentations
-
Pro - static
-
What's new in the Airways
-
Flash talks on angioedema
-
2e media test sympo
-
Test media Industry
-
Test Baptiste
-
Immunotherapy
-
Test Mélanie
-
Q&A
-
Q&A
-
Q&A
-
Pretest
-
Pretest
-
Romania
-
Germany
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Q&A
-
Obesity
-
Q&A
-
Mastocytosis and mast cells
-
Mastocytosis and mast cells
-
What's new in the Gut
-
Patient case outcomes
-
Diagnostic Challenges of IEI
-
Test Baptiste 2
-
Test Baptiste 3
-
Closing remarks
-
What's new in the Skin
-
Allied health and primary care
-
Allied health and primary care
-
The airway smooth muscle cells
-
Flash talks on COVID 19
-
Flash talks on exposome
-
Oral abstract session 1
-
Oral abstract session 2
-
Oral abstract session 3
-
Oral abstract session 4
-
Basic immunology
-
Treasurer report
-
Practice Stage 2
-
Cow's milk immunotherapy
-
Post-test
-
Post-test
-
Flash talks on urticaria
-
Flash talks on atopic dermatitis
-
Closing statement
-
Closing statement
-
Q&A and close
-
Presentation test
-
Presentation Test
-
Atopic dermatitis
-
Electronic health
-
Test Presentation
-
Test presentation
-
Test Presentation
-
Test Presentation
-
Recommendations for immunotherapy
-
Biomarkers
-
Biomarkers
-
Basic immunology 1
-
Basic immunology 1
-
Flash talks on anaphylaxis
-
Pediatrics
-
Pediatrics
-
Basic immunology 2
-
Mechanisms supporting the new nomenclature
-
Basic immunology 3
-
Exhaled Biomarkers
-
Biological samples
-
FPIES Pathogenesis
-
Breasfeeding a baby with cow's milk allergy
-
Pediatric post-covid manifestations
-
Q&A and Closing remarks
-
Flash talks on food allergy
-
Test Practice stage
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Novel immuno-assays
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Presidential report
-
The Recommendations
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Advances in allergen immunotherapy I
-
Breast-feeding and maternal exposure
-
Dermatology
-
Urticaria: still unmet needs
-
Biologicals
-
Test Axelle
-
Test Adèle
-
(Don't) leave the kids alone
-
Pro-rebutal
-
Con-rebutal
-
Pro-rebutal
-
Con-rebutal
-
Biologicals
-
Advances in allergen Immunotherapy II
-
Welcome address from the Local Chairs
-
Approaches to educating the community
-
Test session Plenary
-
Test session Plenary
-
Flash talks on drug allergy I
-
Fungi and antimicotic therapy
-
Adress the latest from topics
-
Novel Approaches in Food Immunotherapy
-
Is GINA Step 1 and Step 2 mild astham?
-
Biodiversity
-
Flash talks on drug allergy II
-
Flash talks on allergen Immunotherapy I
-
Revisiting the skin immunology
-
Questions and answers
-
Live Q&A
-
Update in Anaphylaxis
-
Social Media
-
Session Test
-
Test Adrienn
-
Pro-rebuttal
-
Con-rebuttal
-
Pro-rebuttal
-
Con-rebuttal
-
EoE Pathogenesis and diagnosis
-
Perioperative allergy
-
Jak kinase inhibitors
-
Questions and answers
-
Flash talks on allergen immunotherapy II
-
Fixed drug exanthem due to Cotrimoxazole
-
Advances in Allergen Immunotherapy (AIT)
-
Flash talks on immunomodulation
-
Allergen immunotherapy
-
The microplastic story
-
EAACI General Assembly
-
JM case report session
-
Test session Symposium
-
Test session Symposium
-
Dermatology 1
-
Dermatology 1
-
Panel Q&A
-
"Vaping: Impact on the Airway”
-
Dermatology 2
-
Biologicals 1
-
Immunomodulatory strategies for:
-
Flash talks on pediatric allergy
-
Chair's Close
-
Role of basophils in anaphylaxis
-
PRO & CON
-
Dermatology 2
-
Biologicals 2
-
Dermatology 3
-
Lessons from the clinical trials
-
Smartinhalers
-
EoE treatment
-
"My mom doen't breastfeed me: what's now?"
-
Epithelial cell biology
-
JMA Poster presentation
-
The Implementation Plan
-
Atopy and Mental Health
-
Food allergy in the adult patient
-
Skin microbiota-host interactions
-
Phase 2 studies with birch pollen
-
Phase 3 studies with birch pollen
-
Introduction to mini master class
-
One Health for paediatric allergy
Show more Sessions (535)Show Less-
-
Iran - Iranian Society of Asthma and Allergy
-
Turkey - Academy of Pediatric Allergy and Asthma (CAAAD)
-
Saudi Arabia - Saudi Allergy Asthma & Immunology Society (SAAIS)
-
Cuba - Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Korea - Korean Academy of Asthma, Allergy, and Clinical Immunology (KAAACI)
-
Albania - Albanian Society of Allergy, Asthma and Clinical Immunology (ASAACI)
-
Spain - Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
-
Asia Pacific - Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
-
Bulgaria
Show more Member societies (7)Show Less-
-
Launch of the PAI Virtual Issue on Asthma & EnvironmentIn an effort to further elucidate the environmental factors that are central to our unders...
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma ManagementThe European Academy of Allergy and Clinical Immunology (EAACI) have designed a short onli...
-
EAACI's Research and Outreach Committee (ROC): Advancing Allergy, Asthma, and Clinical Immunology Research and CareHamburg, Germany June, 8th 2023 – The European Academy of Allergy and Clinical Immun...
-
EAACI Launches the Knowledge HubWe have a huge new update for you! EAACI is proud to announce the launch of the EAACI Know...
Show more News (2)Show Less-
-
Martin Chapman
-
Bashir Omarjee
-
Kenji Kabashima
-
Martin Bachmann
-
Anat Shavit
-
Kathleen May
-
Jason Ohayon
-
Irene Bartha
-
Heather J Bax
-
Maria Kostara
-
Elisabeth Laderman
-
Sabina Wuenschmann
-
Marcia Podesta
-
Eva Untersmayr
-
Karin Hartmann
-
Esther Raskopf
-
Raj Khera
-
Martha Cabrera
-
Eva Untersmayr
-
Elizabeth Tham
-
Kavitha Sooriyakumar
-
Nicolas Charles
-
Ferdaous Chahed
-
Veena Viswanath
-
Lennart Riemann
-
Giulia Costanzo
-
Oliver Hausmann
-
Johannes Schmid
-
Sandra Ekström
-
Rasha Khaliliya
-
Yaicith Arevalo
-
Ayel Batac
-
Tiago Rama
-
Lars Lange
-
Sayeh Agah
-
Anna Smola
-
Franziska Roth-Walter
-
Jean-Christoph Caubet
-
Carsten Schmidt-Weber
-
Martin Wagenmann
-
Jonathan Spergel
-
Elizabeth Palmer
-
Anand Srivastava
-
Márcia Quaresma
-
Eleni Anastasiou
-
Samuel Ailsworth
-
Paolo Palma
-
Liam Heaney
-
Josh Lawson
-
Abena Amoah
-
Agnes Csuth
-
Adam Chaker
-
Yannis Hara
-
J Mahadevan
-
Yasutaka Mitamura
-
Avraham Beigelman
-
Massimo Triggiani
-
Atharva Karmalkar
-
Harshita Shailesh
-
Giovanni Costanzo
-
Catharina Chatain
-
Krasimira Baynova
-
Aila Fakhimahmadi
-
Avraham Beigelman
-
Jonathan Hourihane
-
Sebastian Johnston
-
Jonathan Bernstein
-
Marta Ferrer
-
Mare Lõhmus
-
Tobias Welte
-
Tamar Landau
-
Carmen Vidal
-
Carmen Galan
-
Michael Gerstlauer
-
Kai Yamazaki
-
James Harker
-
Sanghwa Youm
-
Katsumasa Kitamura
-
Hasan Bayram
-
Audrey Kamga
-
Bogdan Stana
-
Justina Sematonyte
-
Jonas Lander
-
Beatriz Moya
-
Tetsuo Shoda
-
Pamela Waked
-
Yat Laam Lee
-
Natasa Kusic
-
Janet Davies
-
Riccardo Castagnoli
-
Katharina Blümchen
-
Mariia Kryvopustova
-
Sonya Vysochanskaya
-
Liam O'Mahony
-
Marcus Maurer
-
Doris Kollman
-
Jean Bousquet
-
Martina Votto
-
Klaus F. Rabe
-
Stefan Vieths
-
Pascal Demoly
-
Markus Ollert
-
Antti Lauerma
-
Clive Grattan
-
Leif Hanitsch
-
Jasper Kappen
-
Elena Petkova
-
Ismail Ogulur
-
Jan Gutermuth
-
Markus Magerl
-
Claus Bachert
-
Peter Howarth
-
Mohammad Issa
-
Anna Kosowska
-
Margitta Worm
-
Liat Nachshon
-
Hitomi Kubota
-
Daina Bastyte
-
Thomas Werfel
-
Orianne Dumas
-
Naoko Inomata
-
Nicholas West
-
Leif Hanitsch
-
Leif Hanitsch
-
Martin Liška
-
Anete Grumach
-
Oskar Bergman
-
Cassim Akhoon
-
Artem Zharkov
-
Pascal Gasser
-
Ichiro Nomura
-
Ishikawa Chie
-
Natalya Ellis
-
Stephan Gabet
-
Naomi Woodman
-
Jasper Kappen
-
Tamila Shumna
-
Jiangchuan He
-
Rosita Castillo Loja
-
Dinastry Pramadita Zakiudin
-
Graham Roberts
-
Adnan Custovic
-
Kohei Hasegawa
-
Alina Gherasim
-
Zsolt Komlósi
-
Hideaki Morita
-
Stephanie Korn
-
Anna Globinska
-
Natalija Novak
-
Pascal Krenger
-
Olena Mozyrska
-
Anaïs Lemoine
-
Nicholas Ready
-
Katherine Pose
-
Francesca Mori
-
Andreas Pinter
-
Atsuhito Nakao
-
Sabine Schnadt
-
Max Bermingham
-
Thomas Severin
-
Marta Andúgar
-
Jaime Bernaola
-
Jitesh Chauhan
-
Ishino Takashi
-
Igor Kaidashev
-
Cristina Lopes
-
Masaki Orihara
-
Thomas Kündig
-
Matteo Martini
-